Researchers at University College London (UCL) have issued a warning regarding the safety and efficacy of the menopause supplement market. their analysis suggests many products are either nutritionally deficient or contain ingredients that could cause serious health issues.
The £18.4 million "menopause gold rush"
The global market for menopause supplements is expanding at a rapid pace, with projjections suggesting it would exceed £18.4 million by 2023. This commercial surge is occurring as approximately 13 million women in the UK navigate perimenopause or menopause, a transition that typically takes place between the ages of 45 and 55.
As these women experience physical symptoms like hot flushes, palpitations, and difficulty sleeping,a massive market has emerged. According to the UCL study, social media personalities often market these pills as proven remedies, even when scientific data is absent. Professor Joyce Harper, the study's lead author, noted that this trend contributes to widespread misinformation, leading women to spend large sums on "dummy pills."
Risks of liver toxicity and vitamin D overdose
Beyond being ineffective, some supplements may pose direct threats to physical health. Poppy Sullivan, a menopause expert at UCL, specifically pointed to the herb black cohosh, which is often used to treat night sweats but carries a known risk of liver toxicity.
The report also warns that excessive intake of certain vitamins can be dangerous. For instance, high doses of vitamin D can lead to elevated calcium levels, which might result in vomiting, confusion, or even organ damage. These risks highlight the danger of consuming unverified botanical ingredients in high doses.
Why 50% of products lack essential calcium and vitamin D
While the International Menopause Society states that calcium is vital for preventing osteoporosis, the UCL investigation found that less than a quarter of the analyzed supplements included bone-boosting calcium. This is a significant gap given the health risks associated with post-menopause bone density loss.
Similarly, although the British Menopause Society recommends a daily 10mcg vitamin D supplement for women of menopausal age, roughly half of the products studied failed to provide this essential nutrient. Instead, many brands rely on herbal compounds, such as red clover, which are intended to mimic the effects of estrogen in the body.
The £1.50 to £95 monthly price discrepancy
The study identified a massive price gap, with monthly costs for these supplements swinging from as little as £1.50 to as much as £95. This wide range suggests that consumers may be paying a significant premium for products that offer little more than standard herbal ingredients.
Dr. Anne-Marie Boylan, an expert in qualitative health research at the University of Oxford, suggested that many of these expensive ingredients might be found more cheaply in general multivitamins or even through a balanced diet. She noted that while medical advice remains the best option for quality-of-life symptoms, some women may hesitate to seek professional help due to fear of being dismissed.
The urgent call for clinical trials and regulation
A significant question remains regarding the actual efficacy of the herbal compounds used to treat symptoms like brain fog.. Because many claims are not supported by scientific data , the researchers are calling for more high-quality research, including clinical trials, to determine which ingredients are truly safe and effective.
The investigation highlights a pressing need for better regulation to protect the millions of women entering this life stage. Without stricter oversight, the current market may continue to prioritize profit over the scientific evidence required to ensure patient safety.
Comments 0